Background: Ganglion impar block (GIB) is a commonly used interventional option for refractory chronic coccydynia. Caudal epidural steroid injection (CESI) targets the sacral and coccygeal roots and may theoretically augment the analgesic efficacy of GIB. Evidence comparing GIB alone with a combined GIB and CESI approach, however, remains limited. This study compared long‐term pain outcomes after GIB monotherapy versus GIB combined with CESI. Methods: In this retrospective single‐center study (Jan 2020–May 2025), we evaluated 56 adults with chronic coccydynia who underwent GIB alone (Group A) or in combination with CESI (Group B). Pain intensity was assessed using the 11‐point numeric rating scale (NRS‐11) at baseline and at 1 h, 1 month, and 6 months after the procedure. Multivariable logistic regression was used to explore predictors of 6‐month response, including early postprocedural pain change and sex. Results: Significant improvements in pain intensity were observed in both groups and sustained over 6 months. Responder rates at 6 months were comparable between the GIB‐only (41.7%) and GIB with CESI (45.0%) groups ( p > 0.05). Multivariable analysis revealed that greater early pain relief (baseline to 1 h) significantly predicted 6‐month favorable outcomes (OR: 2.08; 95% CI: 1.26–3.42; p = 0.004), whereas male sex was associated with significantly reduced odds of response (OR: 0.11; 95% CI: 0.02–0.72; p = 0.022). Conclusions: In this single‐center retrospective cohort, GIB was associated with sustained pain relief in a substantial proportion of patients with chronic coccydynia, while the addition of CESI did not confer a clear incremental benefit. Importantly, immediate postprocedural pain relief served as a robust predictor of long‐term success, whereas male sex was identified as a negative prognostic factor. Prospective, adequately powered randomized trials are needed to confirm these exploratory findings and to refine patient selection for GIB‐based interventions. Trial Registration: ClinicalTrials.gov Identifier: NCT07200765
Catheter breakage is a rare complication of continuous peripheral nerve blocks. Retained fragments pose a significant technical challenge, particularly when they migrate from the insertion site. We report a 39‐year‐old woman with Fabry disease and chronic foot pain refractory to pharmacologic therapy who, after a successful diagnostic posterior tibial nerve block, received a continuous peripheral nerve catheter. She initially experienced excellent analgesia but, by Day 4, developed severe neuropathic symptoms; imaging showed proximal migration of a catheter fragment. Computed tomography and fluoroscopy guided surgical retrieval of the fragment was performed. This case highlights the need for early recognition of catheter‐related complications, precise localization with advanced imaging, and timely surgical intervention to reduce adverse outcomes from retained catheter fragments.
Ganglion impar block (GIB) is a commonly used interventional option for refractory chronic coccydynia. Caudal epidural steroid injection (CESI) targets the sacral and coccygeal roots and may theoretically augment the analgesic efficacy of GIB. Evidence comparing GIB alone with a combined GIB and CESI approach, however, remains limited. This study compared long‐term pain outcomes after GIB monotherapy versus GIB combined with CESI. In this retrospective single‐center study (Jan 2020–May 2025), we evaluated 56 adults with chronic coccydynia who underwent GIB alone (Group A) or in combination with CESI (Group B). Pain intensity was assessed using the 11‐point numeric rating scale (NRS‐11) at baseline and at 1 h, 1 month, and 6 months after the procedure. Multivariable logistic regression was used to explore predictors of 6‐month response, including early postprocedural pain change and sex. Significant improvements in pain intensity were observed in both groups and sustained over 6 months. Responder rates at 6 months were comparable between the GIB‐only (41.7%) and GIB with CESI (45.0%) groups (p > 0.05). Multivariable analysis revealed that greater early pain relief (baseline to 1 h) significantly predicted 6‐month favorable outcomes (OR: 2.08; 95% CI: 1.26–3.42; p = 0.004), whereas male sex was associated with significantly reduced odds of response (OR: 0.11; 95% CI: 0.02–0.72; p = 0.022). In this single‐center retrospective cohort, GIB was associated with sustained pain relief in a substantial proportion of patients with chronic coccydynia, while the addition of CESI did not confer a clear incremental benefit. Importantly, immediate postprocedural pain relief served as a robust predictor of long‐term success, whereas male sex was identified as a negative prognostic factor. Prospective, adequately powered randomized trials are needed to confirm these exploratory findings and to refine patient selection for GIB‐based interventions. Trial Registration: ClinicalTrials.gov Identifier: NCT07200765
8 October 2026 in Journal of Back and Musculoskeletal Rehabilitation
Background: Lumbosacral transitional vertebrae (LSTV) are a common congenital anomaly that often remain underrecognized in patients with low back pain (LBP), potentially leading to inappropriate management and disability. Objective: To determine the prevalence and distribution of LSTV subtypes in a large LBP cohort and to evaluate functional disability and healthcare utilization in patients with LSTV. Methods: In this single-center retrospective observational study, electronic records of 20,395 patients presenting with LBP between January 1, 2018 and January 1, 2024 were reviewed. Lumbar and lumbosacral imaging was evaluated and LSTV were classified according to the Castellvi system. Functional disability was assessed using the Oswestry Disability Index (ODI) in patients with LSTV. Associations between ODI scores, age, sex, Castellvi subtype and number of outpatient visits were analyzed. Results: LSTV were identified in 405 patients (prevalence 1.98%; mean age 52.9 ± 15.2 years; 63% female). Castellvi Type 2a was the most frequent subtype (25.7%). More than half of the patients reported pain duration of 1–5 years and 67.7% had multiple outpatient visits. Patients with multiple visits had significantly higher ODI scores than those with a single visit (42.65 ± 17.30 vs. 29.53 ± 18.05, p < 0.001) whereas ODI scores did not differ significantly across LSTV subtypes (p > 0.05). Conclusion: In patients with LBP, LSTV were present in approximately 2%. Patients with LSTV demonstrated substantial disability and frequent healthcare utilization. Prospective controlled studies are needed to determine whether these findings are specifically attributable to LSTV and to clarify potential causal relationships.